![]() |
|
|
Forward to a colleague |
||
Access Full Stories The latest twist in Roche's long-running bid to acquire diagnostics expert Ventana has seen the pharma giant announce it intends to elect directors to Ventana's board at its next AGM (annual general meeting)... Read Carl Zeiss licenses 'record-breaking' fluorescence technology Microscopy expert-Carl Zeiss has licensed a new fluorescence microscopy technique that enables scientists to determine the precise intracellular location of proteins of interest... Read ACD/Labs takes the stress out of NMR spectral analysis ACD/Labs has unveiled a new programme designed to help synthetic chemists reduce the amount of time required to spend on NMR (nuclear magnetic resonance) data analysis... Read Microfluidics promises a bright future for cell-based assays UK researchers have published results that show that microfluidic devices can provide robust quantitative pharmacological information from low numbers of single cells... Read Separating mixtures in an NMR machine Canadian researchers have devised a method of extracting the complete proton NMR (nuclear magnetic resonance) spectra for a component of a mixture without the need for physical separation... Read |
|||||||||||||||||
All News Headlines for: December | November | October |
|||||||||||||||||
ZIC®-HILIC Separation of Polar and Hydrophilic Compounds SeQuant is introducing a new ZIC®-HILIC column for ultra-high speed applications. Its potential is illustrated by a complete baseline separation of Oseltamavir (Tamiflu®) from Oseltamavir Carboxylate followed by MS/MS detection in less than 40 seconds... Click Here | |||||||||||||||||
|
Related Industry News GSK allies with OncoMed to beat cancer stem cells GlaxoSmithKline (GSK) and OncoMed are teaming up to develop novel antibody therapies that target the cancer stem cells believed to play a key role in forming cancers... Read Transport wins for elecrokinetic drug delivery Transport Pharmaceuticals has been named the 2007 North American Technology Innovation of the Year Award winner in electrokinesis-enabled drug delivery... Read Eisai continues biologics push with $3.9bn MGI Pharma buy Japanese drugmaker Eisai has agreed to buy US biopharma firm MGI Pharma for $3.9bn (€2.7bn) in a bid to expand its US presence and strengthen its oncology pipeline... Read Galapagos branches out with new GSK deal GlaxoSmithKline (GSK) is the latest drug firm to involve Galapagos in a new development partnership, in a deal worth up to €218m for the Belgian biotech... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||